Lonza Group
Tracked across 4 events · 28 articles · First seen Apr 06, 2026 · Last active Jul 02, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Lonza Group has expanded its strategic collaboration with a leading US-based biopharmaceutical company, adding two biologics programs for commercial production and strengthening long-term commitments. This partnership is expected to generate a multi-billion CHF cumulative value, highlighting Lonza Group's strong position in the CDMO market.
Jul 01, 2026 · 7 articles
Business
Impact: Lonza Group has entered into an exclusive licensing agreement with Antharis Therapeutics, providing its dual-payload ADC technology platform. Lonza Group will manufacture components related to its proprietary payload and linker technologies and is eligible for upfront, milestone, and royalty payments, which is positive for its revenue streams.
Jun 15, 2026 · 6 articles
Business
Impact: Lonza Group is a prominent company in the maleic anhydride market, influencing its development and growth.
Jun 02, 2026 · 7 articles
Domestic
Impact: Lonza Group>>> ended weak, contributing to the mixed performance of the Switzerland>>> market.
May 21, 2026 · 8 articles
ERGEN INTELLIGENCE
Track Lonza Group live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard